Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novel Src kinase inhibitors prepared and tested at Aventis

Feb. 28, 2003

Recent patent covers new PPAR agonists discovered at Dr. Reddy's Laboratories

Feb. 28, 2003

New series of GH secretagogues designed by European research team

Feb. 27, 2003

Manhattan Pharmaceuticals and Atlantic Technology Ventures complete merger

Feb. 27, 2003

Tularik presents novel modulators of UPC3 with utility in obesity and diabetes

Feb. 27, 2003

Positive opinion for Aldurazyme in E.U.

Feb. 26, 2003

Nonthiazolidinedine antidiabetic agent with favorable pharmacological and pharmacokinetic profile

Feb. 25, 2003

Biopure receives additional funding to develop Hemopure for trauma applications

Feb. 25, 2003

Novel DPP-IV inhibitors in early development at Merck

Feb. 25, 2003

Novo Nordisk claims new purine-based DPP-IV inhibitors

Feb. 25, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...